AstraZeneca is investing in the development of computer systems to predict the safety and efficacy of new treatments at a planned Russian operation in St. Petersburg. The Predictive Science Centre, the latest in the London-based drug giant's series of projects in Russia, is expected to tap local talent to create the bioinformatics, data analytics and other tools needed for the new effort. The center appears to be a bet on computer systems to play a greater role in the company's R&D efforts. Item